Order results by:
Issue | Title | |
Vol 12, No 1S (2020): Спецвыпуск: рассеянный склероз | Age at onset in multiple sclerosis as a possible predictor for cognitive impairment in children and adolescents | Abstract similar documents |
M. D. Bogdanova, T. T. Batysheva, Yu. V. Mikadze, R. Ts. Bembeeva, E. Yu. Volkova | ||
"... Pediatric-onset multiple sclerosis (MS) can lead to cognitive impairment (CI). In general ..." | ||
Vol 12, No 1S (2020): Спецвыпуск: рассеянный склероз | Parent-child relationship and family system characteristics in families of adolescents with multiple sclerosis | Abstract similar documents |
E. A. Boyko, E. V. Ivanchuk, K. R. Latii, V. L. Malygin, O. V. Bykova, T. T. Batysheva | ||
"... The incidence of multiple sclerosis (MS) is increasing in all age groups, including children ..." | ||
Vol 13, No 1 (2021) | New possibilities of siponimod therapy in patients with secondary progressive multiple sclerosis | Abstract similar documents |
D. S. Kasatkin, N. V. Khachanova, V. M. Alifirova, A. N. Boyko, K. Z. Bakhtiyarova, Ya. V. Vlasov, M. V. Davydovskaya, E. P. Evdoshenko, S. A. Sivertseva | ||
"... The process of neurodegeneration in multiple sclerosis (MS) remains an urgent problem of modern ..." | ||
Vol 14, No 1S (2022): Спецвыпуск: рассеянный склероз | Results of a study of the quality of life in patients with highly active multiple sclerosis in Russia | Abstract similar documents |
A. N. Boiko, K. Z. Bakhtiyarova, M. A. Sherman, Z. A. Goncharova, I. V. Smagina, T. I. Khaibullin, N. N. Babicheva, N. N. Spirina, I. A. Yampolskaya-Gosteva, I. A. Sokolova, I. V. Greshnova, V. E. Nikitenkova, I. G. Lukashevich, A. V. Inzhinova, N. A. Malkova, D. S. Korobko, O. V. Boyko, I. S. Lozovskaya | ||
"... Multiple sclerosis (MS) is a chronic autoimmune inflammatory demyelinating and neurodegenerative ..." | ||
Vol 8, No 3 (2016) | Epidemiology of multiple sclerosis in the Bryansk Region | Abstract similar documents |
Yu. N. Yurchenko, A. N. Yurchenko, I. V. Smagina | ||
"... Objective: to study the clinical and epidemiological features of multiple sclerosis (MS ..." | ||
Vol 9, No 1 (2017) | Clinical and epidemiological features of patients with multiple sclerosis in the Kursk Region | Abstract similar documents |
V. B. Laskov, E. A. Logacheva, E. E. Tretyakova, M. A. Gridnev | ||
"... Objective: to analyze the regional register of patients with multiple sclerosis (MS) in the Kursk ..." | ||
Vol 12, No 1S (2020): Спецвыпуск: рассеянный склероз | The central vein sign in the differential diagnosis of multiple sclerosis | Abstract similar documents |
S. E. Belov, A. N. Boyko | ||
"... The current diagnosis of multiple sclerosis (MS) is based on confirmation of the disseminated ..." | ||
Vol 15 (2023): (Suppl. 1) | The place of virtual reality in the rehabilitation of patients with multiple sclerosis | Abstract similar documents |
Iu. E. Korzhova, A. A. Fuks, A. S. Klochkov, A. E. Khizhnikova, N. A. Suponeva, M. N. Zakharova | ||
"... Multiple sclerosis (MS) is a chronic autoimmune disease that limits the ability to work and lead ..." | ||
Vol 11, No 4 (2019) | New possibilities for the therapy of secondary progressive multiple sclerosis | Abstract similar documents |
A. M. Petrov, E. V. Ivashkova, I. D. Stolyarov | ||
"... Patients with multiple sclerosis (MS) are at high risk for transition to secondary progressive MS ..." | ||
Vol 11, No 3 (2019) | Clinical recommendations for the use of ocrelizumab in patients with multiple sclerosis | Abstract similar documents |
A. N. Boyko, M. V. Davydovskaya, N. V. Khachanova, M. N. Zakharova, N. N. Spirin, E. V. Popova, V. M. Alifirova, Ya. V. Vlasov, S. A. Sivertseva, F. A. Khabirov, M. V. Shumilina, E. P. Evdoshenko | ||
"... multiple sclerosis and primary progressive multiple sclerosis in the use of ocrelizumab. ..." | ||
Vol 8, No 2 (2016) | Glatiramer acetate 40 mg/ml: A review of the results of GALA and GLACIER clinical studies | Abstract similar documents |
N. Yu. Lashch, A. N. Boiko | ||
"... Multiple sclerosis (MS) is a demyelinating disease of the CNS, which affects mainly young able ..." | ||
Vol 6, No 3 (2014) | Visual evoked potentials in examining the visual analyzer in patients with multiple sclerosis | Abstract similar documents |
S. M. Karpov, Z. B. Pazhigova, E. N. Karpova | ||
"... with multiple sclerosis (MS) to optimize the early diagnosis of the disease. Patients and methods. Seventy-nine ..." | ||
Vol 15 (2023): (Suppl. 1) | MicroRNAs as biomarkers of multiple sclerosis progression | Abstract similar documents |
N. M. Baulina, I. S. Kiselev, O. G. Kulakova, E. V. Popova, O. O. Favorova, A. N. Boyko | ||
"... Multiple sclerosis (MS) is an autoimmune inflammatory neurodegenerative disease of the central ..." | ||
Vol 10, No 1 (2018) | New drugs for anti-B-cell therapy of multiple sclerosis | Abstract similar documents |
A. N. Boyko, N. Yu. Lashch, M. E. Guseva | ||
"... for multiple sclerosis (MS) and the results of clinical trials of ocrelizumab, the first drug of this group ..." | ||
Vol 8, No 1 (2016) | Multiple sclerosis-related fatigue and possibilities of its correction | Abstract similar documents |
N. Yu. Lashch, A. N. Boiko | ||
"... Multiple sclerosis (MS)-related fatigue is encountered in 75–92% of patients and it is one ..." | ||
Vol 15, No 6 (2023) | Ofatumumab – the first fully human monoclonal antibody approved for the treatment of multiple sclerosis | Abstract similar documents |
E. V. Popova | ||
"... Currently, more than 15 molecules are already approved for the treatment of multiple sclerosis ..." | ||
Vol 7, No 1S (2015): Special issue "Epilepsy" | Epilepsy in patients with multiple sclerosis: specific features of diagnosis and therapy | Abstract similar documents |
Yu. A. Belova, T. I. Yaukushina, I. G. Rudakova, S. V. Kotov | ||
"... Once the symptoms of multiple sclerosis (MS) occur, the risk of developing epilepsy within 5 years ..." | ||
Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз | Influence of von Willebrand factor on common pathophysiological mechanisms of cerebrovascular diseases and multiple sclerosis | Abstract similar documents |
I. A. Koltsov, M. Yu. Martynov, A. N. Yasamanova, I. A. Shchukin, M. S. Fidler, A. N. Boyko | ||
"... to the development/progression of many diseases, including cerebrovascular disease and multiple sclerosis. Von ..." | ||
Vol 11, No 1 (2019) | Experience with anti-B-cell therapy in the pathogenetic treatment of multiple sclerosis | Abstract PDF (Eng) similar documents |
O. V. Boyko, S. V. Petrov, N. Yu. Lashch, M. R. Guseva, A. N. Boyko | ||
"... One of the promising areas in the pathogenetic treatment of multiple sclerosis (MS) is anti-B-cell ..." | ||
Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз | Art therapy possibilities in the complex treatment of patients with multiple sclerosis | Abstract similar documents |
M. E. Guseva, O. V. Matvievskaya, A. N. Boyko | ||
"... -progressive multiple sclerosis (MS). Patients and methods. A group of 42 patients (5 men and 37 women, mean ..." | ||
Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз | Attitude to reproduced disease modifying therapies in patients with relapsing-remitting multiple sclerosis: results of a medical and sociological study | Abstract similar documents |
Ya. V. Vlasov, M. V. Churakov, E. V. Sineok, A. N. Boyko | ||
"... The problem of an adequate choice of a treatment method in multiple sclerosis (MS) remains one ..." | ||
Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз | Current ethical issues of clinical trials of drugs for the pathogenetic therapy of multiple sclerosis in the context of the COVID-19 pandemic | Abstract similar documents |
E. V. Ivashkova, A. M. Petrov, M. V. Votintseva, I. D. Stolyarov | ||
"... institutions in terms of research for new multiple sclerosis (MS) treatments. In this review we discuss ..." | ||
Vol 15, No 4 (2023) | Paramagnetic rim sign in multiple sclerosis | Abstract similar documents |
D. V. Kapkanets, S. E. Belov, M. B. Dolgushin, A. N. Boyko | ||
"... To date, there is no accepted highly specific pattern for the detection of multiple sclerosis ..." | ||
Vol 11, No 4 (2019) | Recommendations from the Expert Meeting «Secondary progressive multiple sclerosis: unresolved issues and prospects» | Abstract similar documents |
N. V. Khachanova, A. N. Boyko, K. Z. Bakhtiyarova, Ya. V. Vlasov, E. P. Evdoshenko, S. A. Sivertseva, T. E. Schmidt, M. V. Shumilina | ||
"... progressive multiple sclerosis (MS) (SPMS), clinical trials, and promising treatments for the progressive MS ..." | ||
Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз | Clinical presentation and course of multiple sclerosis in patients with herpesvirus infection | Abstract similar documents |
M. S. Gris, N. S. Baranova, N. N. Spirin, D. S. Kasatkin, D. V. Kiselev, E. G. Shipova | ||
"... for multiple sclerosis (MS) in the presence of persistent herpesvirus infection (PHVI) remain poorly understood ..." | ||
Vol 15 (2023): (Suppl. 1) | Contribution of B-lymphocytes to the production of Interleukin-17 in multiple sclerosis | Abstract similar documents |
N. V. Sursyakova, E. M. Kuklina, T. V. Baidina, I. V. Nekrasova, T. N. Trushnikova | ||
"... The study of pathogenic systems involved in multiple sclerosis (MS) is essential ..." | ||
Vol 13, No 2 (2021) | COVID-19 vaccination guidelines for patients with multiple sclerosis | Abstract similar documents |
N. V. Khachanova, N. A. Totolyan, Ya. V. Vlasov, S. A. Sivertseva, M. V. Davydovskaya, E. P. Evdoshenko, A. P. Prodeus, M. N. Zakharova, N. N. Spirin, A. N. Boyko | ||
"... with multiple sclerosis (MS) is presented. The authors of the consensus, based on an analysis of a large number ..." | ||
Vol 8, No 4 (2016) | GLATIRAMER ACETATE IS A FIRST-LINE DUAL-ACTION DRUG FOR THE TREATMENT OF RELAPSING-REMITTING MULTIPLE SCLEROSIS | Abstract similar documents |
T. E. Shmidt | ||
"... Multiple sclerosis (MS) is the most common and potentially disabling disease of the central ..." | ||
Vol 10, No 2 (2018) | CLIPPERS syndrome | Abstract similar documents |
T. E. Schmidt, I. N. Pronin, K. Yu. Kazantsev, O. N. Voskresenskaya, I. V. Damulin, A. A. Aleksandrov, N. N. Yakhno | ||
Vol 10, No 3 (2018) | Balo's concentric sclerosis: a clinical case | Abstract PDF (Eng) similar documents |
I. V. Litvinenko, G. N. Bisaga, V. S. Chirsky, R. F. Gimadutdinov, P. S. Dynin, S. Yu. Golokhvastov, V. Yu. Lobzin | ||
"... of the central nervous system (CNS), which is currently classified as multiple sclerosis. In recent years ..." | ||
Vol 13, No 3 (2021) | Results of Expert Council meeting on modern principles of treatment optimization in patients with relapsing-remitting multiple sclerosis using anti-CD20 monoclonal antibody | Abstract similar documents |
A. N. Boyko, N. V. Khachanova, D. S. Korobko, D. S. Kasatkin, Ya. V. Vlasov, E. P. Evdoshenko, E. V. Popova, K. Z. Bakhtiyarova, S. A. Sivertseva | ||
"... The article presents the results of the discussion of the use of anti-B-cell therapy in multiple ..." | ||
Vol 15, No 6 (2023) | MRI assessment of different types of chronic demyelinating lesions in patients with multiple sclerosis using quantitative susceptibility mapping (QSM) | Abstract similar documents |
M. S. Matrosova, V. V. Bryukhov, E. V. Popova, G. N. Belskaya, M. V. Krotenkova | ||
"... Histologically, chronic demyelinating lesions in multiple sclerosis (MS) have been shown ..." | ||
Vol 15 (2023): (Suppl. 1) | Delayed diagnosis of the neuromyelitis optica spectrum disorder | Abstract similar documents |
S. A. Dzhukkaeva, E. V. Ermilova, Sh. R. Nabiev, O. N. Voskresenskaya | ||
Vol 15 (2023): (Suppl. 1) | Clinical course features of atypical demyelinating optic neuritis: case series | Abstract similar documents |
N. L. Sheremet, D. D. Eliseeva, V. V. Bryukhov, N. A. Andreeva, N. V. Zhorzholadze, Yu. K. Murakhovskaya, A. K. Kalashnikova, M. N. Zakharova | ||
"... associated with multiple sclerosis (MS), and atypical ON, which are the main clinical manifestation ..." | ||
Vol 12, No 3 (2020) | Anti-MOG associated myelitis | Abstract PDF (Eng) similar documents |
A. I. Isaykin, O. N. Voskresenskaya, T. I. Kuzminova, E. V. Ermilova, O. V. Stezhko | ||
"... of anti-MOG associated myelitis at the CI-TXlevel. Differential diagnosis was made between multiple ..." | ||
1 - 35 of 35 Items |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)